Aurinia Pharmaceuticals PEG Ratio

Aurinia Pharmaceuticals (AUPH) currently reports a PEG ratio of 14.08. That is above the Healthcare sector average of 11.64. Use the charts on this page to explore Aurinia Pharmaceuticals's PEG ratio history and peer comparisons.

Aurinia Pharmaceuticals's PEG ratio of 14.08 is higher than the Healthcare sector average of 11.64. That is roughly 21.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Aurinia Pharmaceuticals's market price to a fundamental measure such as earnings, sales, or book value. At 14.08, AUPH can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 14.08, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for Aurinia Pharmaceuticals, and consider following AUPH for alerts when major investors trade the stock.

Aurinia Pharmaceuticals is classified in the Healthcare sector. On PEG ratio, it currently shows 14.08 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AUPH with unrelated industries.